Immunologist Ton Schumacher of the Netherlands Cancer Institute, also Professor at Leiden University Medical Center (LUMC), is…
As of this week, enterprising researchers can submit their candidacy for the Fall edition of the Venture…
The Netherlands-based data analytics company, Core Life Analytics, has closed a €1m Series A financing round. The…
Six innovative teams were selected this spring to participate in the Venture Challenge, a coaching programme for…
Last Tuesday, April 7, the Dutch cabinet announced that it will initially make € 100 million available…
Today we are reminded that antibiotics are an important part of treatment regiments not only for severe…
Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr….
Six teams have been selected by NWO for participation in the Venture Challenge Spring 2020 edition. The…
Venture Challenge Alumnus Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for…
Early detection of delirium, quick intervention and good monitoring is of great importance to prevent (permanent) consequential…
The 23rd edition of the Venture Challenge is now open for applications. Deadline is February 25th at…
Dutch medical innovations are rarely granted the Breakthrough Designation by the FDA. Startup ATRO Medical from Nijmegen…
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived…
Fruitful Venture Challenges Ten high potential startups prepared for success with the Venture Challenge. In two editions, ten startups…
After 11 years and 22 successful editions the Venture Challenge has been adopted by the Dutch Ministry…
During the Investors Forumfourteen young companies had the opportunity to present their company to interesting partners and discuss…
Targeting growth in the fight against cancer In front of an audience of companies and organisations whose…
Funding possibilities can vary from finding the perfect match with a VC to receiving a grant issued by a European programme. Where to…
SeraNovo, winner of the Venture Challenge Fall 2018, has signed a License Agreement with Carna Biosciences, a company…
Last week the Venture Challenge Fall 2019 kicked off with five Life Sciences & Health startups participating…
LS@W Expert Classes are a series of targeted workshops organised in close collaboration with industry experts on relevant…
Accelerating innovative startups and scale-ups together As of September 2019, LifeSciences@Work (LS@W) welcomes Pivot Park as new…
Benelux’ largest biotech investor Aat van Herk commits a €20 million investment in diagnostics company SkylineDx after…
Decubitus is extreem pijnlijk voor patiënten, verhoogt de werkdruk van verpleegkundigen en kost jaarlijks €450 miljoen. Bijna…
Na een niertransplantatie hebben nierpatiënten verhoogde kans op virusinfecties, zoals het BK-virus. Op dit moment is er…
Dutch startup Cyclomics is developing a liquid biopsy test for tumor recurrence and therapy response monitoring that…
Ncardia, winner of the Venture Challenge 2009, announced today that following retraction of the Cor.4U product line…
The Interreg project Codex4SMEs (Companion diagnostics expedited for small and medium-sized businesses) project plans to improve healthcare…
The Association of Dutch Health Foundations (SGF) and the Top Sector Life Sciences & Health (LSH) have made €…
Khondrion granted Orphan Drug Designation for KH176 for the treatment of maternally inherited diabetes and deafness (MIDD)…
First-in-class drugs through targeted stabilisation of protein complexes During the Dutch Biotech Event where biotech companies of…
Snelle diagnose en passende behandeling met SpiroNose Binnen enkele minuten kan de elektronische neus “SpiroNose” op basis van…
MyLife Technologies started a first-in-human study with its ceramic nanoporous MicroNeedle Arrays (npMNA) technology at Centre for…
You are ready to start your business, however, is the University or Medical Center ready as well…
BI/OND, Hable, the Jury and the board during the Award Ceremony Student start-up BI/OND is the winner…
Every year LifeSciences@Work organises two Venture Challenges for start-ups that want to translate their idea into a…
VitroScan, previous Value Voucher Alumnus, is developing tests to predict treatment outcome for cancer patients, has closed…
Den Haag, 21 maart 2019 – Carmen van Vilsteren is per 1 april 2019 het nieuwe boegbeeld…
Again a great Friday Afternoon planned for 29 March 2019 about Clinical Trials. Our upcoming Expert Class…
Talent Accelerator Programme for BioBusiness (TAP BioBusiness) is an intensive training programme of eight months in which…
SeraNovo, the formulation startup from Leiden, received a € 300,000 investment from UNIIQ. The investment was announced…
Dengue-virus maakt jaarlijks 400 miljoen mensen ziek Wereldwijd worden elk jaar zo’n vierhonderd miljoen mensen ziek door…
Tackling a stubborn drug problem If drugs do not dissolve well, they cannot be absorbed by the…
Did you invent a lifesaving therapy, diagnostic or medical device? Or a groundbreaking technology that enables faster…
Great Friday Afternoon planned for 15 February 2019 about Health Technology Assessment (HTA) and Reimbursement. Our upcoming…
Health~Holland is proud to present the latest and greatest of the Life Sciences & Health sector. This…
Charles River will offer access to ToxTracker®, expanding the Company’s portfolio of genetic toxicology assays Charles River…
ATRO Medical BV has permission from the Healthcare and Youth Inspection to implant the meniscal prosthesis Trammpolin®…
At the Dutch Life Sciences conference, Marc van Moorsel MSc., co-founder of IOVA pitched their business plan…
De Leidse startup MyLife Technologies heeft een alternatief ontwikkeld voor naaldinjecties en orale tabletten en capsules om…
Today at the Dutch Life Science Conference, Chrétien Herben, director of the LifeSciences@Work Accelerator, announced SeraNovo as…
LifeSciences@Work started in 2008, and now in 2018, it proudly celebrates its tenth anniversary. To mark this…
nov 12, 2018 Prolira develops the DeltaScan, which enables better and earlier detection of delirium. This way…
Innovatiefonds FundiQare investeert in het jonge Delftse bedrijf Momo Medical, Venture Challenge deelnemer van 2017. De startup…
Deze week start in Erasmus MC een pilot: de ReceptIVFity test wordt gedurende een periode van enkele…
Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for the treatment of cancer and other…
Every year LifeSciences@Work organises two Venture Challenges for startups that want to develop their idea into a…
KHENERGY study provides first data on safety and efficacy of KH176 in patients with mitochondrial disease Results…
The multi-site CiPA Phase II Myocyte Validation report by Blinova et al. is now available! The LS@W…
On 05-09-2018 the first two patients were treated with QuiremSpheres®, the only commercially available holmium-166 based microspheres…
NIJMEGEN, the Netherlands – The Netherlands – Khondrion, a leading clinical-stage pharmaceutical company focusing on small molecule…
A breakthrough in the development of antibiotics against resistant bacteria Carduso Capital invests in the Groningen start-up…
A breakthrough in the early detection of cervical cancer screening Carduso Capital invests in the Groningen start-up…
During the 5th edition of the Gerard and Anton Awards, STENTiT and Usono were selected as one…
STENTiT obtains financial support from MKB Innovatiestimulering Topsectoren Zuid-Nederland (MIT-Zuid). This program will provide funds to conduct…
The next online course Clinical Development from Paul Janssen Futurelab will start on September 24, 2018. At…
Maarsseveen, The Netherlands, 29 June 2018 – Today at the Dutch Biotech Event, Chrétien Herben, director of…
LS@W Expert Classes are a series of targeted workshops organised in close collaboration with industry experts on relevant topics…
LS@W Expert Classes are a series of targeted workshops organised in close collaboration with industry experts on relevant topics…
Het midden- en kleinbedrijf (MKB) werkzaam in de Life Sciences & Health (LSH) sector is doorgaans op…
Cergentis, a Dutch biotech company and LS@W alumnus, announced that it secured a > €1.2 million grant…
Royal Philips announced that it has acquired NightBalance, a digital health scale-up company based in the Netherlands and…
The new Health~Holland Update April 2018 edition is out now. In this spring magazine we highlight that…
Over the last years EdgeLeap discovered that one of the key challenges of their clients is the…
Every year LifeSciences@Work organises two Venture Challenges for startups that want to develop their idea into a…
STENTiT will present at this year’s PCR Innovators Day Paris. In a session dedicated to stents and…
As a starting entrepreneur in Life Sciences one faces multiple challenges. Within the Value Centre of LS@W…
LifeSciences@Work Alumnus Rianne de Vries (Amsterdam Medical Centre) won the Public prize at the Lung days 2018….
From 03 – 07 June the Task Force Health Care (TFHC) in cooperation with Association Innovative Medicine,…
Terumo and LS@W alumnus Quirem welcome an important milestone for QuiremSpheres® in the Netherlands and in Europe….
Detecting cancer tumors early: Scientists who do not choose a paper, but explore whether their invention is…
On February 8th, Venture Challenge Alumnus CC Diagnostics presented a pledge. By means of this pledge CC…
LS@W Startup NutriLeads announces that its NUTRI-NEED project has been selected for €2.5 million funding under the…
Obtaining a patent is a crucial step to safeguard the intellectual property (IP) of your novel biomedical…
The Venture Challenge is our bi-annual coaching programme. This Spring we will organise the 19th edition. After the…
Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that it has agreed…
Let us guide you in taking the next steps with your startup. 2017 will offer you the…
We are pleased to send you this special edition of the Health~Holland Update, this magazine features the…
We are pleased to send you the Health~Holland Year in Review 2017, the yearly magazine that reflects…
Meniscusprothese van ATRO Medical dichterbij door investering Soepeler bewegen, minder pijn en vijf tot tien jaar uitstel…
We would like to welcome ambitious biomedical professionals who want to boost their careers and broaden their…
De Topsector Life Sciences & Health (Health~Holland) publiceert het nieuwe Kennis- en Innovatiecontract 2018-2019, getiteld Glow~Motion. Dit…
Find below our experts who will be contributing to our Expert Classes 4 & 5. Join us…
We are pleased to send you the last Health~Holland Update of 2017, our magazine that brings you…
Maastricht, The Netherlands, 28 November 2017 – Cristal Therapeutics, a clinical stage biopharmaceutical company developing targeted nanomedicines…
Gosselies, Belgium, 17th November 2017 – Ncardia, an emerging drug discovery and development stem cell technology company…
Today at the Dutch Life Sciences Conference 2017, Chrétien Herben, director of the LifeSciences@Work Accelerator, announced Cyclomics…
Somnox: 1 year later.. and many steps further. What started as an idea of four students of…
In our recent LS@W Newsletter we announced the upcoming Expert Class, in which editions 4 and 5…
Na een succesvolle eerste Health~Holland Meet~Up, waar zorgprofessionals en innovatieve startups met elkaar in verbinding zijn gebracht,…
Recent Comments